Shinichi Imafuku

Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, placebo-controlled phase 3 POETYK PSO-1 trial

April W. Armstrong, Melinda Gooderham, Richard B. Warren et al. · Journal of the American Academy of Dermatology · 2022 · 316 citations · Full text

Efficacy and safety of secukinumab in patients with generalized pustular psoriasis: A 52‐week analysis from phase <scp>III</scp> open‐label multicenter Japanese study

Shinichi Imafuku, Masaru Honma, Yukari Okubo et al. · The Journal of Dermatology · 2016 · 186 citations

Efficacy and Safety of Tralokinumab in Adolescents With Moderate to Severe Atopic Dermatitis

Amy S. Paller, Carsten Flohr, Michael J. Cork et al. · JAMA Dermatology · 2023 · 120 citations · Full text

A Phase 2 Randomized Trial of Apremilast in Patients with Atopic Dermatitis

Eric L. Simpson, Shinichi Imafuku, Yves Poulin et al. · Journal of Investigative Dermatology · 2018 · 116 citations

Oral tofacitinib efficacy, safety and tolerability in Japanese patients with moderate to severe plaque psoriasis and psoriatic arthritis: A randomized, double‐blind, phase 3 study

Akihiko Asahina, Takafumi Etoh, Atsuyuki Igarashi et al. · The Journal of Dermatology · 2016 · 84 citations · Full text